Roy Blunt actually said...

"I think in fiscal year 2009, the agency failed to meet one-third of its drug review goals and approximately 20 percent of its device review goals."

"The administration's request for FDA is an increase of 16 percent more than the current funding level."

"And particularly catfish."

"I would also be pleased to see the numbers for fiscal year 2010, if they are available now."